Cerebellar phenotypes in germline PTEN mutation carriers
Neuropathology and Applied Neurobiology · 2024
DOI: 10.1111/nan.12970 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuropathology and Applied Neurobiology, 2024. Verfasst von Donatella Gambini und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurorehabilitation Sciences, Casa di Cura Igea, Milan, Italy. Hauptthemen laut MEDLINE: Hamartoma Syndrome, Multiple, Cerebellar Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 118 Literaturangaben.
Abstract (Originalsprache)
PTEN hamartoma tumour syndrome (PHTS) comprises different hereditary conditions caused by germline PTEN mutations, predisposing to the development of multiple hamartomas in many body tissues and also increasing the risk of some types of cancer. Cerebellar involvement in PHTS patients has been long known due to the development of a pathognomonic cerebellar hamartoma (known as dysplastic gangliocytoma of the cerebellum or Lhermitte‐Duclos disease). Recently, a crucial role of the cerebellum has been highlighted in the pathogenesis of autism spectrum disorders, now recognised as a phenotype expressed in a variable percentage of PHTS children. In addition, rare PTEN variants are indeed identified in medulloblastoma as well, even if they are less frequent than other germline gene mutations. The importance of PTEN and its downstream signalling enzymatic pathways, PI3K/AKT/mTOR, has been studied at different levels in both human clinical settings and animal models, not only leading to a better understanding of the pathogenesis of different disorders but, most importantly, to identify potential targets for specific therapies. In particular, PTEN integrity makes an important contribution to the normal development of tissue architecture in the nervous system, including the cerebellum. Thus, in patients with PTEN germline mutations, the cerebellum is an affected organ that is increasingly recognised in different disorders, whereas, in animal models, cerebellar Pten loss causes a variety of functional and histological alterations. In this review, we summarise the range of cerebellar involvement observed in PHTS and its relationships with germline PTEN mutations, along with the phenotypes expressed by murine models with PTEN deficiency in cerebellar tissue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurorehabilitation Sciences, Casa di Cura Igea, Milan, Italy.
- Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.
- Pathology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
- Human Pathology and Molecular Pathology Unit, TOMA Advanced Biomedical Assays, Busto Arsizio, Italy.
ORCID-Profile: Elisabetta Kuhn
Zitieren
APA
Gambini, D., Ferrero, S., Bulfamante, G., Pisani, L., Corbo, M., & Kuhn, E. (2024). Cerebellar phenotypes in germline PTEN mutation carriers. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/nan.12970
Vancouver
Gambini D, Ferrero S, Bulfamante G, Pisani L, Corbo M, Kuhn E. Cerebellar phenotypes in germline PTEN mutation carriers. Neuropathology and Applied Neurobiology. 2024. doi:10.1111/nan.12970
BibTeX
@article{Gambini2024,
author = {Gambini, Donatella and Ferrero, Stefano and Bulfamante, Gaetano and Pisani, Luigi and Corbo, Massimo and Kuhn, Elisabetta},
title = {Cerebellar phenotypes in germline PTEN mutation carriers},
journal = {Neuropathology and Applied Neurobiology},
year = {2024},
doi = {10.1111/nan.12970}
}
EUVIMED